Viewing nowGluem Sustained Release Tablet (Metformin Hydrochloride)
Metformin Hydrochloride 500mg
Tablet · Prescription medication
Samik Pharmaceutical Co., Ltd.

MFDS item code 201402909 · Approved 2014.06.30 · Insurance code 644003450
Treatment of type 2 diabetes mellitus in adults
This medication is used to effectively control the blood sugar levels in adult patients with type 2 diabetes who do not achieve adequate control with diet and exercise alone, especially in overweight diabetic patients. It can be used alone or in combination with other oral hypoglycemic agents or insulin to enhance its therapeutic effect. This helps in stabilizing blood sugar levels for better diabetes management.
The dose should be determined individually based on the drug's efficacy and tolerability, and should not exceed the recommended maximum daily dose. - The usual starting dose is metformin hydrochloride extended-release tablets 500mg once daily with the evening meal. - Blood glucose levels should be measured after one week and the dose adjusted. Gastrointestinal adverse reactions may improve with gradual dose increases. The maximum dose is 2000mg per day. - When increasing the dose, increase it by 500mg each week; up to a maximum of 2000mg per day may be taken with the evening meal. If glycemic control is not achieved with a maximum of 2000mg once daily, consider administering 1000mg twice daily; both doses should be taken with meals. - For patients already being treated with metformin tablets, the initial dose of this product is the same as the daily dose of immediate-release metformin tablets. Switching to this product is not recommended for patients taking more than 2000mg per day of immediate-release metformin tablets. - At initiation of treatment and during dose adjustment, fasting blood glucose should be measured to assess response to this drug and determine the minimum effective dose. Blood glycosylated hemoglobin levels should be measured at approximately 3-month intervals. - The goal of treatment with this drug, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycosylated hemoglobin levels to normal or near-normal levels using the minimum effective dose. Patients with renal impairment This drug may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~ <60ml/min or glomerular filtration rate (GFR) 45≤~ <60 mL/min/1.73 m2) who do not have other conditions that may increase the risk of lactic acidosis, using the following dose adjustment. - The starting dose is 500mg or 750mg once daily. The maximum daily dose is 1000mg. Renal function should be monitored closely every 3- 6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73m2, this drug should be discontinued immediately.
This medication may rarely cause a serious condition known as lactic acidosis, which requires utmost caution. Lactic acidosis is a dangerous condition caused by excessive accumulation of lactic acid in the body, potentially leading to death if untreated. Additionally, when used with insulin or sulfonylureas, severe hypoglycemia may occur, thus careful monitoring of blood sugar levels is necessary. Patients with moderate to severe renal impairment, dehydration, severe infection, or cardiovascular diseases should not use this medication. Specifically, it is contraindicated in patients experiencing acute myocardial infarction, shock, or sepsis. This medication must be temporarily discontinued before and after examinations using iodine-containing radiological contrast agents, and can only be resumed after ensuring normal renal function post-examination. Those with hypersensitivity to this medication, type 1 diabetes, ketoacidosis, serious infections, or acute or unstable heart failure should not use this drug. Patients with very poor nutritional status, adrenal insufficiency, liver dysfunction, or excessive alcohol consumption should also exercise caution when using this medication. While receiving treatment with this drug, renal function should be regularly monitored, especially in older adults or patients with decreased renal function, who should be checked more frequently. Gastrointestinal disturbances can occur commonly; initially, symptoms such as nausea, vomiting, diarrhea, and abdominal pain may arise, but usually improve over time. However, caution is necessary if severe diarrhea or vomiting persists due to the risk of dehydration. During the use of this medication, excessive alcohol consumption should be avoided, as alcohol intake can increase the risk of lactic acidosis. During pregnancy, the growth condition of the fetus should be closely monitored, and this medication is not recommended in cases of placental insufficiency or preeclampsia. Breastfeeding women should consult with a doctor regarding whether to continue breastfeeding or discontinue the medication since it is secreted in breast milk. This medication has not been established as safe and effective in children, thus it is not recommended for individuals under 17 years of age. In case of overdose, hypoglycemia is rare, but there is a risk of lactic acidosis; thus, immediate medical attention is required, and treatments like blood dialysis may be necessary. This medication may interact with various other drugs, hence if other medications are being taken, it's essential to inform the doctor or pharmacist, particularly when co-administering with drugs that may affect renal function. Lastly, this medication should not be chewed or crushed and should be swallowed whole; it is normal for the tablet shell to pass in the stool.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. Additionally, it should be kept at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain the effectiveness of the medication for a longer period.
White, double-convex, rectangular sustained release tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMetformin Hydrochloride 500mg
Tablet · Prescription medication
Samik Pharmaceutical Co., Ltd.

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Celltrion Pharmaceuticals)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ildong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ilseong IS Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Kyungdong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 250mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Youngpoong Pharmaceutical Co., Ltd.)
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.